{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:03:30Z","timestamp":1788462210050,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"a Grant-in-Aid to Saitama Medical University","award":["No. 16-B-1-13"],"award-info":[{"award-number":["No. 16-B-1-13"]}]},{"name":"a Grant-in-Aid to Saitama Medical Center","award":["No. 27-F-1-08"],"award-info":[{"award-number":["No. 27-F-1-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MYC-associated factor X (MAX) is a protein in the basic helix-loop-helix leucine zipper family, which is ubiquitously and constitutively expressed in various normal tissues and tumors. MAX protein mediates various cellular functions such as proliferation, differentiation, and apoptosis through the MYC-MAX protein complex. Recently, it has been reported that MYC regulates the proliferation of anaplastic large cell lymphoma. However, the expression and function of MAX in anaplastic large cell lymphoma remain to be elucidated. We herein investigated MAX expression in anaplastic large cell lymphoma (ALCL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) and found 11 of 37 patients (30%) with ALCL lacked MAX expression, whereas 15 of 15 patients (100%) with PTCL-NOS expressed MAX protein. ALCL patients lacking MAX expression had a significantly inferior prognosis compared with patients having MAX expression. Moreover, patients without MAX expression significantly had histological non-common variants, which were mainly detected in aggressive ALCL cases. Immunohistochemical analysis showed that MAX expression was related to the expression of MYC and cytotoxic molecules. These findings demonstrate that lack of MAX expression is a potential poor prognostic biomarker in ALCL and a candidate marker for differential diagnosis of ALCL and PTCL-NOS.<\/jats:p>","DOI":"10.1038\/s41598-020-67500-w","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T10:03:02Z","timestamp":1593079382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Takahisa","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihide","family":"Tokuhira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Tamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"67500_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","volume":"66","author":"H Stein","year":"1985","unstructured":"Stein, H. et al. The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66, 848\u2013858 (1985).","journal-title":"Blood"},{"key":"67500_CR2","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar, E. R. et al. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124, 1473\u20131480. https:\/\/doi.org\/10.1182\/blood-2014-04-571091 (2014).","journal-title":"Blood"},{"key":"67500_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2017.01.003","volume":"64","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Human Pathol. 64, 19\u201327. https:\/\/doi.org\/10.1016\/j.humpath.2017.01.003 (2017).","journal-title":"Human Pathol."},{"key":"67500_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/pas.0000000000000500","volume":"40","author":"RL King","year":"2016","unstructured":"King, R. L. et al. Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Am. J. Surg. Pathol. 40, 36\u201343. https:\/\/doi.org\/10.1097\/pas.0000000000000500 (2016).","journal-title":"Am. J. Surg. Pathol."},{"key":"67500_CR5","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","volume":"120","author":"G Vasmatzis","year":"2012","unstructured":"Vasmatzis, G. et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120, 2280\u20132289. https:\/\/doi.org\/10.1182\/blood-2012-03-419937 (2012).","journal-title":"Blood"},{"key":"67500_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pin.12758","volume":"69","author":"T Yamashita","year":"2019","unstructured":"Yamashita, T. et al. Anaplastic large cell lymphoma with TP63 rearrangement: a dismal prognosis. Pathol. Int. 69, 155\u2013159. https:\/\/doi.org\/10.1111\/pin.12758 (2019).","journal-title":"Pathol. Int."},{"key":"67500_CR7","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1158\/0008-5472.can-11-3891","volume":"72","author":"A Cascon","year":"2012","unstructured":"Cascon, A. & Robledo, M. MAX and MYC: a heritable breakup. Cancer Res. 72, 3119\u20133124. https:\/\/doi.org\/10.1158\/0008-5472.can-11-3891 (2012).","journal-title":"Cancer Res."},{"key":"67500_CR8","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.3324\/haematol.2016.143768","volume":"101","author":"R Manso","year":"2016","unstructured":"Manso, R. et al. C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas. Haematologica 101, e336-338. https:\/\/doi.org\/10.3324\/haematol.2016.143768 (2016).","journal-title":"Haematologica"},{"key":"67500_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccell.2017.06.001","volume":"32","author":"Y Gu","year":"2017","unstructured":"Gu, Y. et al. Stabilization of the c-Myc protein by CAMKII\u03b3 promotes T cell lymphoma. Cancer Cell 32, 115-128.e117. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.001 (2017).","journal-title":"Cancer Cell"},{"key":"67500_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ajh.21887","volume":"86","author":"H Moritake","year":"2011","unstructured":"Moritake, H. et al. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: identification of a novel fusion gene ALO17\/C-MYC. Am. J. Hematol. 86, 75\u201378. https:\/\/doi.org\/10.1002\/ajh.21887 (2011).","journal-title":"Am. J. Hematol."},{"key":"67500_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2014-08-594507","volume":"125","author":"A Weilemann","year":"2015","unstructured":"Weilemann, A. et al. Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma. Blood 125, 124\u2013132. https:\/\/doi.org\/10.1182\/blood-2014-08-594507 (2015).","journal-title":"Blood"},{"key":"67500_CR12","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1182\/blood.V83.12.3581.3581","volume":"83","author":"G Inghirami","year":"1994","unstructured":"Inghirami, G. et al. Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 83, 3581\u20133590 (1994).","journal-title":"Blood"},{"key":"67500_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2159-8290.cd-13-0799","volume":"4","author":"OA Romero","year":"2014","unstructured":"Romero, O. A. et al. MAX inactivation in small cell lung cancer disrupts MYC-SWI\/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 4, 292\u2013303. https:\/\/doi.org\/10.1158\/2159-8290.cd-13-0799 (2014).","journal-title":"Cancer Discov."},{"key":"67500_CR14","doi-asserted-by":"publisher","first-page":"14674","DOI":"10.1038\/ncomms14674","volume":"8","author":"IM Schaefer","year":"2017","unstructured":"Schaefer, I. M. et al. MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation. Nat. Commun. 8, 14674. https:\/\/doi.org\/10.1038\/ncomms14674 (2017).","journal-title":"Nat. Commun."},{"key":"67500_CR15","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1158\/1078-0432.ccr-12-0160","volume":"18","author":"N Burnichon","year":"2012","unstructured":"Burnichon, N. et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 18, 2828\u20132837. https:\/\/doi.org\/10.1158\/1078-0432.ccr-12-0160 (2012).","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"key":"67500_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1442-200x.1999.01140.x","volume":"41","author":"Y Yuza","year":"1999","unstructured":"Yuza, Y., Kawakami, M., Takagi, K., Yamazaki, Y. & Urashima, M. Max protein expression is associated with survival of children with lymphoblastic lymphoma. Pediatr. Int. Off. J. Jpn. Pediatr. Soc. 41, 637\u2013640 (1999).","journal-title":"Pediatr. Int. Off. J. Jpn. Pediatr. Soc."},{"key":"67500_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00277-007-0289-3","volume":"86","author":"JS Grewal","year":"2007","unstructured":"Grewal, J. S. et al. Highly aggressive ALK-positive anaplastic large cell lymphoma with a leukemic phase and multi-organ involvement: a report of three cases and a review of the literature. Ann. Hematol. 86, 499\u2013508. https:\/\/doi.org\/10.1007\/s00277-007-0289-3 (2007).","journal-title":"Ann. Hematol."},{"key":"67500_CR18","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood.V96.6.2172","volume":"96","author":"R Suzuki","year":"2000","unstructured":"Suzuki, R. et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype. Blood 96, 2993\u20133000 (2000).","journal-title":"Blood"},{"key":"67500_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-8722-5-38","volume":"5","author":"YF Wang","year":"2012","unstructured":"Wang, Y. F. et al. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients. J. Hematol. Oncol. 5, 38. https:\/\/doi.org\/10.1186\/1756-8722-5-38 (2012).","journal-title":"J. Hematol. Oncol."},{"key":"67500_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0002-9440(10)64248-4","volume":"161","author":"EA Raetz","year":"2002","unstructured":"Raetz, E. A. et al. The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas. Am. J. Pathol. 161, 875\u2013883. https:\/\/doi.org\/10.1016\/s0002-9440(10)64248-4 (2002).","journal-title":"Am. J. Pathol."},{"key":"67500_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1365-2559.2007.02674.x","volume":"50","author":"N Asano","year":"2007","unstructured":"Asano, N. et al. Cytotoxic molecule expression is predictive of prognosis in Hodgkin\u2019s-like anaplastic large cell lymphoma. Histopathology 50, 705\u2013715. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02674.x (2007).","journal-title":"Histopathology"},{"key":"67500_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/00000478-199911000-00009","volume":"23","author":"KA Cataldo","year":"1999","unstructured":"Cataldo, K. A. et al. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am. J. Surg. Pathol. 23, 1386\u20131392. https:\/\/doi.org\/10.1097\/00000478-199911000-00009 (1999).","journal-title":"Am. J. Surg. Pathol."},{"key":"67500_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0037-1963(03)00132-X","volume":"40","author":"ES Jaffe","year":"2003","unstructured":"Jaffe, E. S., Krenacs, L. & Raffeld, M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin. Hematol. 40, 175\u2013184 (2003).","journal-title":"Semin. Hematol."},{"key":"67500_CR24","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1200\/jco.2011.36.5411","volume":"29","author":"L Lamant","year":"2011","unstructured":"Lamant, L. et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 29, 4669\u20134676. https:\/\/doi.org\/10.1200\/jco.2011.36.5411 (2011).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"67500_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo, R. et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27, 516\u2013532. https:\/\/doi.org\/10.1016\/j.ccell.2015.03.006 (2015).","journal-title":"Cancer Cell"},{"key":"67500_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","volume":"127","author":"I Scarfo","year":"2016","unstructured":"Scarfo, I. et al. Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood 127, 221\u2013232. https:\/\/doi.org\/10.1182\/blood-2014-12-614503 (2016).","journal-title":"Blood"},{"key":"67500_CR27","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal, J. et al. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123, 2915\u20132923. https:\/\/doi.org\/10.1182\/blood-2013-11-536359 (2014).","journal-title":"Blood"},{"key":"67500_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/ijo.2017.4031","volume":"51","author":"T Yamashita","year":"2017","unstructured":"Yamashita, T., Higashi, M., Momose, S., Morozumi, M. & Tamaru, J. I. Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer. Int. J. Oncol. 51, 579\u2013586. https:\/\/doi.org\/10.3892\/ijo.2017.4031 (2017).","journal-title":"Int. J. Oncol."},{"key":"67500_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.21406","volume":"84","author":"A Broyde","year":"2009","unstructured":"Broyde, A. et al. Role and prognostic significance of the Ki-67 index in non-Hodgkin\u2019s lymphoma. Am. J. Hematol. 84, 338\u2013343. https:\/\/doi.org\/10.1002\/ajh.21406 (2009).","journal-title":"Am. J. Hematol."},{"key":"67500_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/modpathol.2010.225","volume":"24","author":"DA Wada","year":"2011","unstructured":"Wada, D. A. et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc. 24, 596\u2013605. https:\/\/doi.org\/10.1038\/modpathol.2010.225 (2011).","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67500-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67500-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:57:30Z","timestamp":1670331450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67500-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67500-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"4 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10391"}}